Forum Rewind 2022

Publication Highlights

Diversity, Equity and Inclusion in Cancer Care Resolving healthcare disparities among racial, ethnic and socio-economic groups. Page 4

NCODA Center of Excellence Medically Integrated Pharmacy Accreditation An overview and update on NCODA’s recently-launched accreditation program. Page 4

Advanced Renal Cell Carcinoma: CLEARing Up First-Line Treatment A look at key differences and considerations between first-line treatments for advanced RCC, including TKI and IO toxicity issues. Page 5

Be the MONARCH of Your DESTINY: Recent Updates in Breast Cancer Updates in metastatic HER2+ and adjuvant hormone-receptor positive breast cancer treatment based on the newly-published DESTINY-Breast03 and monarchE trials. Page 5

Treatment of BRAF V600E Mutated and HER2-Amplified Metastatic Colorectal Cancer An analysis of the latest literature for these two rare genetic mutations. Page 6

A Different EGFR Mutation (EGFR Exon 20) Requires New Treatment Approaches in NSCLC The use of amivantamab or mobocertinib in patients with a non-small cell lung cancer exon 20 insertion mutation. Page 7

How Legislation Impacts Oncology: Identifying Disparities in the PBM System Timing and testimony are vital to passing legislative initiatives to counter PBMs. Page 7

Prior Auths and Multiple Appeal Process: Building a Stronger Appeal Clear communication is key for PAs involving precision medicines. Page 8

Navigating Value-Based Contracts US Oncology Network’s approach focuses on total cost of care & the use of biosimilars. Page 8

Integrative Medicine In Cancer Care: Optimizing Your Patients’ Experience An overview of evidence-based integrative medicine that can be used by patients as adjunct treatment to conventional care. Page 9

Integrative Oncology: Whole-Person Care Empowering patients to become an active member in their own care improves quality of life, reduces anxiety and decreases symptoms of stress. Page 9

Using Technology to Improve the Safety, Quality and Productivity of Sterile Compounding A look at IV workflow management systems and robotics, and how these innovations could enhance pharmacy workflow, safety and standardization

Improving Care Coordination for Patients on Oral Oncolytic Therapy How improving. Page 10g the alignment of oral oncolytics with office visits and dispensing can lead to better outcomes. Page 10

New Options for Patients: 2022 Oral Oncology Update An overview of novel oral oncolytics and expanded indications approved in the last year. Page 11

Putting Positive Quality Interventions Into Action: Consistent Clinical Standards & NCODA Resources for Medically Integrated Teams A panel presentation on the use of Oral Chemotherapy Education / Intravenous Cancer Treatment Education sheets and Treatment Support Kits, and how to put a PQI into Action. Page 11